Four out of 6 AML cases in the present study showed aberrant expression of CD7. This was in consistent with previous reports which was reported that CD7 was consistently highly expressed in all mutant NOTCH-1 AML specimens (Takam Kamga et al., 2019). The gene discussed is CD7; the disease is acute myeloid leukemia.